ELISA JONES: Open Payments
NPI 1679007462 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 36 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $767
Food & beverage: $748Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $179 |
| Lilly USA, LLC | 7 | $139 |
| Novo Nordisk Inc | 4 | $71 |
| Exact Sciences Corporation | 3 | $69 |
| Corcept Therapeutics | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| SANOFI PASTEUR INC. | 1 | $33 |
| Amgen Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
Products named: MOUNJARO, AIRSUPRA, BREZTRI, Rybelsus, Cologuard Collection Kit, Korlym, Kerendia, JARDIANCE.
Industry payments across MD — which companies pay providers there.
